Health & Wellness

National Leader in Pancreatic Cancer Opens Unique Clinical Trials in Morristown


Dr. Angela Alistar is national principal investigator for first-in-class drug CPI-613

Morristown, NJ – Atlantic Health System is now enrolling patients in four pancreatic cancer clinical trials.  Angela Alistar, MD, a nationally known expert on pancreatic cancer, is serving as national Principal Investigator (PI) on the first trial and as local PI on three other trials.  In addition, Dr. Alistar will serve as a national and local PI on three additional clinical studies open to enrollment later this year.

“We are fortunate to be able to offer these studies to people with this difficult-to-treat, aggressive cancer,” said Dr. Alistar, who serves as director of GI medical oncology at the Carol G. Simon Cancer Center of Morristown Medical Center, Atlantic Health System. “Our pancreatic cancer program is unique, and our ability to provide access to these clinical trials is one important aspect of our uniqueness. New and more effective treatments are desperately needed.”

Sign Up for E-News

Five-year survival rates for pancreatic cancer are low, even when caught early.  In 2016, pancreatic cancer moved from the fourth leading cause of cancer-related deaths in the U.S. to the third, surpassing breast cancer.

“Dr. Alistar is a leading figure in GI cancer research and treatment, and she has significantly enhanced our ability to care for our patients,” said Eric Whitman, MD, medical director, Atlantic Health System Cancer Care.  “She has expanded Atlantic Health System’s ability to offer participation in clinical trials for pancreatic cancer and other gastrointestinal malignancies, as well as the latest treatments, such as those that work with patients’ immune systems to destroy cancer cells.” 

Pancreatic cancer studies that are currently enrolling patients include:

  • Phase 1 Study of CPI-613 in Combination with Gemcitabine and Nab-Paclitaxel for Patients with Locally Advanced or Metastatic Pancreatic Cancer.  This is a single arm, open-label study of CPI-613, a first-in-class drug with a unique mode of action, in combination with chemotherapeutic agents gemcitabine and nab-paclitaxel.  The study, which is funded by Raphael Pharmaceuticals, Inc., is designed for patients with locally advanced or metastatic pancreatic cancer never treated with systemic chemotherapy. Atlantic Health System is the only program in the world to offer this promising study.  Dr. Alistar led previous studies of this promising drug with pancreatic cancer activity, which have been presented at major international scientific meetings and published in The Lancet Oncology.NCT03435289
  • Phase 2 Study of the Antioxidant BPM31510 (Ubidecarenone, or CoQ10)  Nanosuspension Injection Administered Intravenously With or Without Gemcitabine as 2nd/3rd Line Therapy in Advanced Pancreatic Cancer Patients. This is a Phase 2 multicenter, open-label, non-randomized study to examine the safety and effectiveness of BPM31510 administered as a 144-hour continuous intravenous infusion by itself or in combination with gemcitabine in advanced pancreatic cancer patients as a 2nd / 3rd line therapy. The study is sponsored by Berg LLC and is open at seven total sites in the U.S. Atlantic Health System is the only study site in New Jersey and New YorkNCT02650804 
  • An SU2C Catalyst® Randomized Phase II Trial of the PD1 Inhibitor Pembrolizumab With or Without Vitamin D Receptor Agonist Paricalcitol in Patients With Stage IV Pancreatic Cancer Who Have Been Placed in Best Possible Response. Chemotherapy regimens for pancreatic cancer can now stabilize a patient's cancer and/or place some patients in remission or partial remission. The challenge now is to find options for maintenance therapies that will improve survival and allow continued benefits with minimal toxicities and inconvenience to patients. This study will determine the effects of immunotherapy as one possible maintenance regimen. The study is being conducted to determine the effects that pembrolizumab with or without the addition of paricalcitol may have on pancreatic cancer. Half of the patients will be randomized to receive pembrolizumab (KeytrudaÒ, a monoclonal antibody) plus paricalcitol (synthetic Vitamin D) and half to receive pembrolizumab plus placebo.  This study is sponsored by The Translational Genomics Research Institute. Atlantic Health System’s Morristown Medical Center is the only center on the East Coast that has this study open. NCT03331562
  • Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas. The purpose of this study is to determine the best sequence of   chemotherapy and chemoradiotherapy prior to surgery. This study is sponsored by Alliance and is open nationwide. NCT02839343  

Each study has specific criteria for participation.

To learn more about these studies, please call the Atlantic Center for Research at

(973) 971-6608, contact Dr. Alistar’s office, (973) 971-7960, or visit


About Atlantic Health System

Atlantic Health System, headquartered in Morristown, N.J., is an integrated health care delivery system powered by a workforce of 16,000 team members dedicated to building healthier communities. The system is comprised of 350 sites of care, including six hospitals: Morristown Medical Center, Overlook Medical Center, Newton Medical Center, Chilton Medical Center, Hackettstown Medical Center and Goryeb Children’s Hospital. Atlantic Health System also supports communities through Atlantic Medical Group, Atlantic Rehabilitation, Atlantic Home Care and Hospice, and its subsidiary, Atlantic Ambulance Corporation. Atlantic Health System sponsors the Atlantic Accountable Care Organization, one of the larger ACOs in the nation, and Optimus Healthcare Partners. 

TAP Into Another Town's News:

You May Also Be Interested In

Sign Up for E-News

East Hanover/Florham Park

Florham Park Prepares for the Fourth

Its time for one of Florham Park's shining moments. The Fourth of July parade is not only the kick of to summer, it continues the legacy of being among the oldest Independence day celebrations in New Jersey. this year the festivities are set and the schedule of events is as follows;

9:00am  Flag raising ceremony at the Florham Park Fire House

9:30am  Parade begins on ...

Important Message for Florham Park Residents Regarding the Fourth of July

Important July 4th Celebration Reminder - Please be advised in the interest of safety and security, the entire parade route will be CLOSED TO ALL TRAFFIC beginning at 8:30am on July 4, 2018. This will impact residents who live along the parade route and all of the side streets that connect to the parade route. (Please see the map attached to this post)

Please ensure that you plan accordingly ...

Belmar Parasail: Soar Into Summer with a High-Flying Adventure Along the Beachfront

July 12, 2018

BELMAR, NJ — As Belmar finally basks in picture-perfect weather, it may be time to check off a summer activity on your bucket list. And for many, parasailing is one of those “must-do” experiences.

At Belmar Parasail, the season is in full swing, offering boat trips from the Belmar Manutti Marina to the beachfront where passengers are lifted 500 feet above the Atlantic Ocean ...

New Jersey Average Gas Prrice Down Slightly; Record Holiday Travel Week Underway

Florham Park, N.J.- The average price at the pump in New Jersey is $2.88 today, one cent cheaper than last week ($2.89), according to AAA Northeast’s weekly survey of fuel prices. Today’s average price is 13 cents cheaper than one month ago ($3.01), but 60 cents higher than it was on July 2, 2017 ($2.28).


AAA’s July 2nd survey of ...

LBI Summer Soiree "Boardwalk Nights" on Friday, August 10 at the Sea Shell Resort and Beach Club to Benefit David's Dream and Believe Cancer Foundation

BEACH HAVEN - On August 10, the inaugural LBI Summer Soiree “Boardwalk Nights” (formerly Island Gala) will take  to the breathtaking Sea Shell Resort & Beach Club on Friday, August 10 to benefit David's Dream & Believe Cancer Foundation.

The LBI Summer Soiree is brought to you by key supporting company D. Finelli Construction. David Finelli was ...

Geoffrey the Giraffe Moves In To New Brunswick Children's Hospital

July 12, 2018

NEW BRUNSWICK, NJ - Over a stretch of nearly 70 years, Geoffrey the Giraffe at Toys R Us stores was the symbol of happy times for generations of children, and now he may provide those same feelings for children coming to a hospital.

"From this day forward, Geoffrey stands tall in our lobby to encourage our smallest patients to smile when they enter our facilities," said John ...

Upcoming Events

Tue, July 17, 6:00 PM

CASA of Morris and Sussex Counties, Morristown

CASA Information Session

Education Giving Back Law & Justice

Tue, July 17, 7:00 PM

Livingston Public Library, Livingston

Organically Yours: a wellness experience with ...


Tue, July 24, 7:00 PM

Livingston Public Library, Livingston

Meet the Author: Lucy Tan

Arts & Entertainment

17 Fascinating Facts About Rutgers Athletics

July 10, 2018

NEW BRUNSWICK, NJ - For all the critics of the athletics program at New Jersey’s largest public university, there are more than a dozen reasons to cheer for successes of the sports programs and teams on the playing fields, in classrooms and beyond.

Here are 17 on the field and off the field things this took place this past academic year at Rutgers University:

1. Rutgers had four ...


Beverly Jean (Charlton) Weimar, of Ship Bottom, and Florham Park, New Jersey passed away on March ...
Read more

Education: A Bedrock of Democracy, Civic Engagement and Economic Prosperity

July 5, 2018

More than 240 years ago, our nation’s founders envisioned a country where individuals could forge their own destinies and not be constrained by the circumstances of birth. The essential concept was that people could govern themselves and participate in democracy, or what Benjamin Franklin and others called “a great experiment.” The vision was bold and has flourished as the ...

Kessler Foundation Seeks Volunteers for Important Breast Cancer Study

July 12, 2018

Researchers at Kessler Foundation in West Orange, NJ are studying new ways of combating breast cancer-related weakness & fatigue. These symptoms can diminish quality of life & often last long after treatment has ended. If you are a woman aged 40-75, who was diagnosed with breast cancer within the past 10 years*, you may qualify for this important research study.

We are ...